Tajuddin Sabir Shaikh
Director of Finance/CFO presso Emcure Pharmaceuticals Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Samit Satish Mehta | M | 44 |
Emcure Pharma UK Ltd.
 Emcure Pharma UK Ltd. Medical DistributorsDistribution Services Part of Emcure Pharmaceuticals Ltd., Emcure Pharma UK Ltd. is a wholesaler of pharmaceutical products. The private company is based in Luton, UK.
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 21 anni |
| Bashyam Renganathan | M | - |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India.
The Institute of Cost & Works Accountants of India
| 3 anni |
| Namita Vikas Thapar | F | 47 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 18 anni |
| Hitesh Jain | M | 50 |
Emcure Pharma UK Ltd.
Emcure Pharma UK Ltd. Medical DistributorsDistribution Services Part of Emcure Pharmaceuticals Ltd., Emcure Pharma UK Ltd. is a wholesaler of pharmaceutical products. The private company is based in Luton, UK.
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
| Satish Ramanlal Mehta | M | 73 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 43 anni |
| Berjis Minoo Desai | M | 67 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 27 anni |
| Narinder Kumar | M | 55 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Shardul Doshi | M | - |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| J. Nagarajan | M | - |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Vidya Rajiv Yeravdekar | M | 59 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 3 anni |
| Hanuman Kumar Sharma | M | 50 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Parag Joglekar | M | - |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Chandrasekaran Prabhakaran | M | 49 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Sunil Rajanikant Mehta | M | 61 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 41 anni |
| Gopalkrishnan Ramaswamy | M | - |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Arun Mittal | M | 57 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Sandeep Sikka | M | 53 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Palamadai S. Jayakumar | M | 62 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 4 anni |
| D. Balaji | M | - |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Vijay Laxmi | F | 51 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Vinod Jain | M | 67 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Venkataraman Ramachandran | M | 52 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Suman Ghose Hazra | M | 71 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Sanjay Khandelwal | M | 59 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Dhruv Chandra Mathur | M | - |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Sanjeev Churiwala | M | 54 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Bharat Shah | M | - |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Jayanta Kumar Haribandhu Pani | M | 53 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Valliyur Hariharan Ramakrishnan | M | 83 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Vijay Gokhale | M | 65 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 3 anni |
| Mangesh S. Sawant | M | 65 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Vepa Vallinath | M | 67 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Anurag Bansal | M | 49 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Ashish Aggarwal | M | 46 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Gopalakrishnan Iyer | M | - |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Kamal Kishore Baheti | M | 61 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Ramesh Swaminathan | M | 59 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Mukund Keshao Gurjar | M | 70 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 23 anni |
| Narasimhan Raghunathan | M | - |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Pawan Kumar Agarwal | M | 57 |
The Institute of Cost & Works Accountants of India
The Institute of Chartered Accountants of India
| - |
| Jyoti Rani | F | - |
The Institute of Cost & Works Accountants of India
| - |
| Kirti Prataprai Sanghvi | F | 65 |
The Institute of Cost & Works Accountants of India
| - |
| Sekhar Kumar Halder | M | 67 |
The Institute of Cost & Works Accountants of India
| - |
| Gopala Ramanan Balasubramaniam | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Chandrashekar S. Joshi | M | 66 |
The Institute of Cost & Works Accountants of India
| - |
| Deepak Gupta | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Subodh Kumar | M | 39 |
The Institute of Cost & Works Accountants of India
| - |
| Surender Suyal | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Hareshkumar Suthar | M | 33 |
The Institute of Cost & Works Accountants of India
| - |
| Aparajita Brahma | F | - |
The Institute of Cost & Works Accountants of India
| - |
| Areti Narasimha Rao | M | 52 |
The Institute of Cost & Works Accountants of India
| - |
| Ramesh Raghavan Puducheri | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Thiyagarajan Kumar | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Reena Sharma | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Kandathil Nainan Mathew | M | 71 |
The Institute of Cost & Works Accountants of India
| - |
| Maitri Kirankumar Mehta | M | 42 |
The Institute of Cost & Works Accountants of India
| - |
| Meenakshi Ankit Pansari | F | - |
The Institute of Cost & Works Accountants of India
| - |
| Ramesh Kumar Dash | M | 59 |
The Institute of Cost & Works Accountants of India
| - |
| C. S. Sathiyanarayanan | M | 53 |
The Institute of Cost & Works Accountants of India
| - |
| Subhadeepta Paul | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Sirisha Chintapalli | F | 43 |
The Institute of Cost & Works Accountants of India
| - |
| Subhash Kumar | M | 62 |
The Institute of Cost & Works Accountants of India
| - |
| Pomila Jaspal | F | 60 |
The Institute of Cost & Works Accountants of India
| - |
| T. V. Venkataraman | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Nitesh Tanwar | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Ravi Iyer | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Bharat Bhushan Chadha | M | 87 |
The Institute of Cost & Works Accountants of India
| - |
| Raj Kishor Khandelwal | M | 62 |
The Institute of Cost & Works Accountants of India
| - |
| Chakrapani Mohan | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Biswas Jagabandhu | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Debjit Bhattacharya | M | 57 |
The Institute of Cost & Works Accountants of India
| - |
| Subramaniam Kalyanaraman | M | 59 |
The Institute of Cost & Works Accountants of India
| - |
| Ganapathy Vishwanathan | M | 60 |
The Institute of Cost & Works Accountants of India
| - |
| Dinesh Arya | M | 67 |
The Institute of Cost & Works Accountants of India
| 19 anni |
| V. K. Mishra | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Krishna Kumar Lakshmanan | M | 65 |
The Institute of Cost & Works Accountants of India
| - |
| Sujit Chakravorti | M | 80 |
The Institute of Cost & Works Accountants of India
| - |
| Ashutosh Agarwal | M | 58 |
The Institute of Cost & Works Accountants of India
| - |
| Kamal Kishore Gupta | M | 78 |
The Institute of Cost & Works Accountants of India
| - |
| Dileep Chinubhai Choksi | M | 74 |
The Institute of Cost & Works Accountants of India
| - |
| Rajeev Jhawar | M | 50 |
The Institute of Cost & Works Accountants of India
| - |
| Gopal Pallipuram Srinivasan | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Kashinath Martu Pai | M | 71 |
The Institute of Cost & Works Accountants of India
| - |
| Rajesh Jacob | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Rangaswamy Soundararajan | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Raamamurthy Manigandann | M | 45 |
The Institute of Cost & Works Accountants of India
| - |
| Vivek Valsaraj | M | 51 |
The Institute of Cost & Works Accountants of India
| - |
| Ramaswamy Srinivasan | M | 72 |
The Institute of Cost & Works Accountants of India
| - |
| Subhashish Datta | M | 57 |
The Institute of Cost & Works Accountants of India
| - |
| Jayashree Ramaswamy | F | - |
The Institute of Cost & Works Accountants of India
| - |
| Surajit Dutta | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Rohni Kumar Gupta | M | 72 |
The Institute of Cost & Works Accountants of India
| - |
| Sundaram Balasubramanian | M | 81 |
The Institute of Cost & Works Accountants of India
| - |
| Murali Sivaraman | M | 63 |
The Institute of Cost & Works Accountants of India
| - |
| Nimesh Salot | M | 54 |
The Institute of Cost & Works Accountants of India
| - |
| K. Ganapathi Subramanian | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Sanjay Jain | M | 54 |
The Institute of Cost & Works Accountants of India
| - |
| Visalakshi Sridhar | F | 58 |
The Institute of Cost & Works Accountants of India
| - |
| Manish Jain | M | - |
The Institute of Cost & Works Accountants of India
| - |
| Ritika Agarwal | F | - |
The Institute of Cost & Works Accountants of India
| - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| India | 100 | 100.00% |
| Regno Unito | 2 | 2.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Tajuddin Sabir Shaikh
- Contatti personali
